Platform
Company
Immunology & Autoimmune
Review status
Currently under review
Pending specialist review and validation.
This test evaluates how your platelets clump together when they are stimulated by collagen, using an electrical impedance method performed on whole blood. It detects the change in electrical resistance created as platelets adhere to sensor wires and aggregate after activation.
Collagen is a natural trigger that platelets encounter at an injured blood vessel, so this assay mimics an early step in normal clot formation. It is often performed alongside other platelet activation studies to provide a fuller picture of overall platelet function.
Clinicians use this test to investigate easy bruising, frequent nosebleeds, heavy menstrual bleeding, or unexpected bleeding during or after procedures when a platelet problem is suspected. It helps assess inherited or acquired platelet function disorders and can contribute to the evaluation of von Willebrand disease. It is also used to check the effect of antiplatelet medicines.
Results can inform decisions about further testing, the timing of surgeries or dental work, and how best to manage medications. An abnormal result on its own does not diagnose a condition, but it points to patterns that, combined with your history, examination, and other laboratory findings, help clarify bleeding risk or how you respond to treatment.
A lower than expected response suggests reduced platelet aggregation. This can happen if you recently took certain medicines, if your platelet count is low, with some systemic illnesses, or due to specific inherited platelet signaling problems. Issues with how the sample was collected or handled can also reduce the response, so your care team may confirm unexpected findings with a repeat test.
A higher than expected response may reflect increased platelet reactivity or normal variation. Your clinician will interpret your result together with other agonist studies, your complete blood count, and your bleeding history. If results are unclear or do not match your symptoms, follow-up may include repeating the test, adjusting medication timing, or ordering additional studies. Seek urgent medical attention if you have ongoing significant bleeding or symptoms that worry you.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Aspirin, nonsteroidal anti-inflammatory drugs, P2Y12 inhibitors (such as clopidogrel, prasugrel, ticagrelor), glycoprotein IIb/IIIa inhibitors, selective serotonin reuptake inhibitors, alcohol, and supplements like fish oil, ginkgo, or garlic can reduce or alter platelet aggregation.
Delays between blood draw and testing, incorrect anticoagulant ratio, vigorous shaking, improper temperature, or prolonged transport can artifactually lower aggregation, leading to misleading results.
Very low platelet counts or significant anemia or polycythemia can affect impedance measurements and may blunt or exaggerate the observed response independent of true platelet function.
Kidney failure, liver disease, severe infection, inflammatory states, and some myeloproliferative disorders can change platelet reactivity and influence the test pattern.
Recent platelet transfusion, cardiopulmonary bypass, or major surgery can transiently change platelet behavior, making results difficult to interpret.
Physiologic changes in pregnancy and differences in children or older adults can influence platelet responses, so context and age-appropriate interpretation are important.
References